TABLE 3.
Adherence and cytotoxicity of CTLPa to epithelial cells
| Pretreatmentb | % Adherencec | SAAPNAd | % Cytotoxicitye |
|---|---|---|---|
| PBS | 100 ± 9.6 | 100 ± 2.0 | 100 ± 1.6 |
| Anti-CTLP IgG | 92 ± 11.2 | 38 ± 3.9 | 87 ± 6.3 |
| Rabbit IgG | 98 ± 14.1 | 100 ± 0.3 | 97 ± 5.1 |
| PMSF | 73 ± 1.3 | 6.2 ± 1.5 | 71 ± 3.2 |
| TLCK | 100 ± 3.2 | 88 ± 11.6 | 96 ± 0.4 |
| TPCK | 85 ± 1.6 | 12.8 ± 3.3 | 83 ± 5.0 |
| PMSF + anti-CTLP | 46 ± 7.3 | 8.4 ± 1.0 | 42 ± 4.0 |
CTLP was used at 0.15 μg per ml. Assays were conducted at room temperature.
Samples were pretreated by incubation for 1 h and washed by ultrafiltration.
Adherence to glutaraldehyde-fixed PLE cells after a 1-h challenge, detected by anti-CTLP IgG, is expressed as a percentage of that for the PBS-treated control.
Chymotrypsin-like activity of pretreated CTLP before the PLE challenge, as measured by cleavage of the chromogenic substrate.
Cytotoxicity to PLE cells after a 1-h challenge, as measured by release of cytoplasmic LDH, is expressed as a percentage of that for the positive-lysis control.